• Kyodo

  • SHARE

The first batch of the coronavirus vaccine developed by U.S. pharmaceutical maker Moderna Inc. arrived in Japan on Friday, with the government planning to use it at mass vaccination centers following expected approval in May.

It will become the second type of shot available in the country after the one developed by Pfizer Inc. if a health ministry panel greenlights it as early as May 20.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)